GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

JD Health International 6618.HK · HKD

Consumer Staples · HKEX · 🇭🇰 Hong Kong

Compare

43.00

-0.60%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About JD Health International

Its shares trade on HKEX under the ticker 6618.HK. It has been listed since 8 December 2020. In the fiscal year to 31 December 2025, it reported revenue of CN¥85.36bn and net income of CN¥6.25bn. At that date it held total assets of CN¥94.86bn and shareholders' equity of CN¥69.85bn.

JD Health International, Inc. operates as an online healthcare platform and retail pharmacy company. The company is headquartered in Beijing, Beijing. The company went IPO on 2020-12-08. The firm mainly providing pharmaceutical and healthcare products and Internet healthcare, health management, intelligent healthcare solutions to the customers, as well as a variety of marketing services to the business partners. The firm mainly conducts its businesses in domestic market.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Consumer Staples
Industry
Consumer Staples Distribution & Retail
Listed since
8 Dec 2020
Employees
2,751

Leadership

Pay as last reported

  • Mr. Qiangdong LiuNon-Executive Chairman of the BoardCN¥407.8m
  • Mr. Enlin JinChief Executive Officer, Executive Director, since 2021CN¥8.4m
  • Ms. Hui DengChief Financial Officer
  • Mr. Ming King ChiuCompany Secretary
  • Mr. Qingqing YiNon-Executive Director
  • Mr. Xingyao ChenIndependent Non-Executive DirectorCN¥476,000
  • Prof. George LauIndependent Non-Executive Director
  • Ms. Ling LiIndependent Non-Executive DirectorCN¥476,000
  • Mr. Ying WuIndependent Non-Executive DirectorCN¥818,000
  • Dr. Jiyu ZhangIndependent Non-Executive DirectorCN¥463,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
82
Environment
99
Social
92
Governance
55
Direct emissions (scope 1)
174.66 t
Energy emissions (scope 2)
5,089.05 t
Value chain emissions (scope 3)
132,954.07 t
Women in the workforce
58.34%
Carbon reduction policy
Yes
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Beijing with 2,751 employees.
  • Operates as an online healthcare platform and retail pharmacy company.
  • Provides pharmaceutical and healthcare products and Internet healthcare services.

Weaknesses

  • Primarily conducts business in the domestic market only.
  • No mention of international presence or expansion plans.
  • Relies on a single market for revenue generation.

Opportunities

  • Potential to expand into international markets.
  • Growth in Internet healthcare and health management services.
  • Increasing demand for pharmaceutical and healthcare products.

Threats

  • Dependence on domestic market may limit growth opportunities.
  • Competition from other healthcare platforms in China.
  • Regulatory changes in the healthcare sector could impact operations.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.